Summary
Updated Aug 31, 2026
Ian Michael Estepan is Chief Operating Officer of Sarepta Therapeutics, Inc. (SRPT). 9 SEC Form 4 filings on record going back to 2024, most recently on 14 March 2026. Most recent open-market trade: sold $294K of SRPT on 19 December 2025. Lifetime open-market sales: $294K.
Recent Transactions
12Every recent SEC Form 4 transaction Ian Michael Estepan has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Ian Michael Estepan go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Ian Michael Estepan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephen Mayo - $123K of SRPT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ian Michael Estepan?
Ian Michael Estepan is a corporate insider, tracked as Chief Operating Officer of Sarepta Therapeutics, Inc. (SRPT). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ian Michael Estepan last file a Form 4?
The most recent primary Form 4 on record is dated 14 March 2026, one of 9 filings going back to 2024.
Has Ian Michael Estepan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($294K) across all tracked filings.
Where can I see all of Ian Michael Estepan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ian Michael Estepan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial